Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute
  • Cancer Prevention and Research Institute of Texas

This publication has 40 references indexed in Scilit: